*** CHEMICAL IDENTIFICATION ***
RTECS NUMBER : DF4936700
CHEMICAL NAME : Benzo(1,2-b:4,3-b')dipyrrole-3(2H)-carboxamide,
7-((1,6-dihydro-4-hydroxy-5-methoxy-7-((4,5,
8,8a-tetrahydro-7-methyl-4-oxocyclopropa(c)pyrrolo(3,
2-e)indol-2(1H)-yl)ca rbonyl)
benzo(1,2-b:4,3-b')dipyrrol-3(2H)-yl)carbonyl)-1,6-di
hydro-4-hydroxy-5-met hoxy-, (7bR)-
CAS REGISTRY NUMBER : 69866-21-3
LAST UPDATED : 199806
DATA ITEMS CITED : 17
MOLECULAR FORMULA : C37-H33-N7-O8
MOLECULAR WEIGHT : 703.77
COMPOUND DESCRIPTOR : Drug
Mutagen
Natural Product
SYNONYMS/TRADE NAMES :
* Antibiotic CC 1065
* CC-1065
* (+)-CC-1065
* NSC 298223
* Rachelmycin
*** HEALTH HAZARD DATA ***
** ACUTE TOXICITY DATA **
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : >8 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
JANTAJ Journal of Antibiotics. (Japan Antibiotics Research Assoc., 2-20-8
Kamiosaki, Shinagawa-ku, Tokyo, 141, Japan) V.2-5, 1948-52; V.21- 1968-
Volume(issue)/page/year: 37,63,1984
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Administration onto the skin
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : >8800 ug/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
JANTAJ Journal of Antibiotics. (Japan Antibiotics Research Assoc., 2-20-8
Kamiosaki, Shinagawa-ku, Tokyo, 141, Japan) V.2-5, 1948-52; V.21- 1968-
Volume(issue)/page/year: 37,63,1984
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Intraperitoneal
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 6900 ng/kg
TOXIC EFFECTS :
Gastrointestinal - other changes
Liver - other changes
Nutritional and Gross Metabolic - weight loss or decreased weight gain
REFERENCE :
JANTAJ Journal of Antibiotics. (Japan Antibiotics Research Assoc., 2-20-8
Kamiosaki, Shinagawa-ku, Tokyo, 141, Japan) V.2-5, 1948-52; V.21- 1968-
Volume(issue)/page/year: 37,63,1984
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Intravenous
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 9 ug/kg
TOXIC EFFECTS :
Gastrointestinal - other changes
Liver - other changes
Nutritional and Gross Metabolic - weight loss or decreased weight gain
REFERENCE :
JANTAJ Journal of Antibiotics. (Japan Antibiotics Research Assoc., 2-20-8
Kamiosaki, Shinagawa-ku, Tokyo, 141, Japan) V.2-5, 1948-52; V.21- 1968-
Volume(issue)/page/year: 37,63,1984
TYPE OF TEST : LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE : Intravenous
SPECIES OBSERVED : Rodent - rabbit
DOSE/DURATION : 1 ug/kg
TOXIC EFFECTS :
Liver - fatty liver degeneration
REFERENCE :
JANTAJ Journal of Antibiotics. (Japan Antibiotics Research Assoc., 2-20-8
Kamiosaki, Shinagawa-ku, Tokyo, 141, Japan) V.2-5, 1948-52; V.21- 1968-
Volume(issue)/page/year: 37,63,1984
** MUTATION DATA **
TYPE OF TEST : Mutation in microorganisms
TEST SYSTEM : Bacteria - Salmonella typhimurium
DOSE/DURATION : 100 ng/L
REFERENCE :
MUTAEX Mutagenesis. (Oxford Univ. Press, Pinkhill House, Southfield Road,
Eynsham, Oxford OX8 1JJ, UK) V.1- 1986- Volume(issue)/page/year: 1,407,1986
TYPE OF TEST : Mutation in microorganisms
TEST SYSTEM : Bacteria - Salmonella typhimurium
DOSE/DURATION : 10 pmol/plate
REFERENCE :
CNREA8 Cancer Research. (Public Ledger Building, Suit 816, 6th & Chestnut
Sts., Philadelphia, PA 19106) V.1- 1941- Volume(issue)/page/year:
48,32,1988
TYPE OF TEST : Micronucleus test
ROUTE OF EXPOSURE : Parenteral
TEST SYSTEM : Rodent - rat
DOSE/DURATION : 200 ug/kg
REFERENCE :
MUTAEX Mutagenesis. (Oxford Univ. Press, Pinkhill House, Southfield Road,
Eynsham, Oxford OX8 1JJ, UK) V.1- 1986- Volume(issue)/page/year: 1,407,1986
TYPE OF TEST : DNA inhibition
TEST SYSTEM : Rodent - mouse Leukocyte
DOSE/DURATION : 4 ug/L
REFERENCE :
CNREA8 Cancer Research. (Public Ledger Building, Suit 816, 6th & Chestnut
Sts., Philadelphia, PA 19106) V.1- 1941- Volume(issue)/page/year:
42,999,1982
TYPE OF TEST : Mutation test systems - not otherwise specified
TEST SYSTEM : Rodent - mouse Leukocyte
DOSE/DURATION : 45 ug/L
REFERENCE :
CNREA8 Cancer Research. (Public Ledger Building, Suit 816, 6th & Chestnut
Sts., Philadelphia, PA 19106) V.1- 1941- Volume(issue)/page/year:
42,999,1982
TYPE OF TEST : DNA inhibition
TEST SYSTEM : Rodent - hamster Ovary
DOSE/DURATION : 150 ng/L
REFERENCE :
CNREA8 Cancer Research. (Public Ledger Building, Suit 816, 6th & Chestnut
Sts., Philadelphia, PA 19106) V.1- 1941- Volume(issue)/page/year:
42,3532,1982
TYPE OF TEST : Mutation test systems - not otherwise specified
TEST SYSTEM : Rodent - hamster Ovary
DOSE/DURATION : 5 ug/L
REFERENCE :
CNREA8 Cancer Research. (Public Ledger Building, Suit 816, 6th & Chestnut
Sts., Philadelphia, PA 19106) V.1- 1941- Volume(issue)/page/year:
42,3532,1982
TYPE OF TEST : Cytogenetic analysis
TEST SYSTEM : Rodent - hamster Lung
DOSE/DURATION : 100 ng/L
REFERENCE :
MUTAEX Mutagenesis. (Oxford Univ. Press, Pinkhill House, Southfield Road,
Eynsham, Oxford OX8 1JJ, UK) V.1- 1986- Volume(issue)/page/year: 1,407,1986
TYPE OF TEST : Sister chromatid exchange
TEST SYSTEM : Rodent - hamster Lung
DOSE/DURATION : 200 ng/L
REFERENCE :
MUTAEX Mutagenesis. (Oxford Univ. Press, Pinkhill House, Southfield Road,
Eynsham, Oxford OX8 1JJ, UK) V.1- 1986- Volume(issue)/page/year: 1,407,1986
TYPE OF TEST : Mutation in mammalian somatic cells
TEST SYSTEM : Rodent - hamster Lung
DOSE/DURATION : 500 ng/L
REFERENCE :
MUTAEX Mutagenesis. (Oxford Univ. Press, Pinkhill House, Southfield Road,
Eynsham, Oxford OX8 1JJ, UK) V.1- 1986- Volume(issue)/page/year: 1,407,1986
TYPE OF TEST : DNA damage
TEST SYSTEM : Mammal - species unspecified Lymphocyte
DOSE/DURATION : 7400 nmol/L
REFERENCE :
CNREA8 Cancer Research. (Public Ledger Building, Suit 816, 6th & Chestnut
Sts., Philadelphia, PA 19106) V.1- 1941- Volume(issue)/page/year:
42,999,1982
*** REVIEWS ***
TOXICOLOGY REVIEW
JANTAJ Journal of Antibiotics. (Japan Antibiotics Research Assoc., 2-20-8
Kamiosaki, Shinagawa-ku, Tokyo, 141, Japan) V.2-5, 1948-52; V.21- 1968-
Volume(issue)/page/year: 39,319,1986
*** END OF RECORD ***
|
|
|
| ALL Chemical Property And Toxicity Analysis PAGES IN THIS GROUP
| | NAME | CAS |
|
2H-(1,3)Benzodioxolo(5,6-a)quinolizine-3-propanenitrile, 1,3,4,6,7,11b-hexahydro-2-oxo-
| 59894-87-0 |
|
2H,7H-Benzo(1,2-b4,5-b')dipyran-2,7-dione
| 54333-75-4 |
|
2H,8H-Benzo(1,2-b4,5-b')dipyran-2,8-dione
| 4413-05-2 |
|
2H,10H-Benzo(1,2-b3,4-b')dipyran-2,10-dione,8,9-dihydro-9-((4-(2-chlorophenyl)-1-piperazinyl)methyl)-4-methyl-
| 78808-05-6 |
|
2H,10H-Benzo(1,2-b3,4-b')dipyran-2,10-dione,8,9-dihydro-9-((4-(3-chlorophenyl)-1-piperazinyl)methyl)-4-methyl-
| 78808-06-7 |
|
2H,10H-Benzo(1,2-b3,4-b')dipyran-2,10-dione,8,9-dihydro-9-((4-(4-chlorophenyl)-1-piperazinyl)methyl)-4-methyl-
| 78808-07-8 |
|
2H,10H-Benzo(1,2-b3,4-b')dipyran-2,10-dione,8,9-dihydro-4-methyl-9-((4-(2-methylphenyl)-1-piperazinyl)methyl)-
| 78808-02-3 |
|
2H,10H-Benzo(1,2-b3,4-b')dipyran-2,10-dione,8,9-dihydro-4-methyl-9-((4-(3-methylphenyl)-1-piperazinyl)methyl)-
| 78808-03-4 |
|
2H,10H-Benzo(1,2-b3,4-b')dipyran-2,10-dione,8,9-dihydro-4-methyl-9-((4-(4-methylphenyl)-1-piperazinyl)methyl)-
| 78808-04-5 |
|
2H,8H-Benzo(1,2-b3,4-b')dipyran-2-one,9,10-dihydro-10-(2-(diethylamino)ethoxy)-8,8-dimethyl-9-hydroxy-, hydrate
| 57802-44-5 |
|
4H-Benzo(5,6)cyclohepta(1,2-d)thiazole,9,10-dihydro-4-(3-(dimethylamino)propylidene)-2-methyl-, monohydrochloride, (Z)-
| 53924-44-0 |
|
1H-Benzocyclohepten-9-ol,2,4a-beta,5,6,7,8,9,9a-beta-octahydro-3,5,5,9-beta-tetramethyl-
| 1891-45-8 |
|
2H,8H-Benzo(1,2-b,3,4-b')dipyran-8-one,5-methoxy-2,2-dimethyl-6-(2-methylcrotonoyl)-10-phenyl-, (E)-
| 548-27-6 |
|
Benzo(1,2-b4,3-b')dipyrrole-1(2H)-carboxamide,5-((5-((3-((acetyloxy)methyl)-3,6-dihydro-7-hydroxy-4-methylbenzo(1,2-b:4,3-b')dipyrrol-1(2H)-yl)carbonyl)-3,6-dihydro -8-hydroxy-7-methoxybenzo(1,2-b:4,3-b')dipyrrol-1(2H)-yl)carbonyl)-3,6-dihydro-8-hydroxy-7-met hoxy-
| 98328-00-8 |
|
Benzo(1,2-b4,3-b')dipyrrole-3(2H)-carboxamide,7-((1,6-dihydro-4-hydroxy-5-methoxy-7-((4,5,8,8a-tetrahydro-7-methyl-4-oxocyclopropa(c)pyrrolo(3,2-e)indol-2(1H)-yl)ca rbonyl)benzo(1,2-b:4,3-b')dipyrrol-3(2H)-yl)carbonyl)-1,6-dihydro-4-hydroxy-5-met hoxy-, (7bR)-
| 69866-21-3 |
|
Benzo(1,2-b4,3-b')dipyrrole-2-carboxylic acid,6-((6-(aminocarbonyl)-3,6,7,8-tetrahydro-5-hydroxy-4-methoxybenzo(1,2-b:4,3-b')dipyrrol-2-yl)carbonyl)-3,6,7,8-tetrah ydro-5-hydroxy-4- methoxy
| 98296-23-2 |
|
Benzo(1,2-b4,3-b')dipyrrole-2-carboxylic acid,8-(chloromethyl)-1,2,3,6,7,8-hexahydro-4-hydroxy-2-methyl-1-oxo-6-((5,6,7-trimethoxy-1H-indol-2-yl)carbonyl)-, methyl ester, (2R-trans)-
| 118292-36-7 |
|
Benzo(1,2-b4,3-b')dipyrrole-2-carboxylic acid,3,6,7,8-tetrahydro-6-acetyl-5-hydroxy-4- methoxy-
| 62874-94-6 |
|
Benzo(1,2-b4,3-b')dipyrrole-2-carboxylic acid,3,6,7,8-tetrahydro-6-(aminocarbonyl)-5-hydroxy-4-methoxy-
| 62497-62-5 |
|
Benzo(1,2-b4,3-b')dipyrrole-1-carboxylic acid,3,6,7,8-tetrahydro-8-(bromomethyl)-4-(((dimethylamino)carbonyl)oxy)-2-methyl-6-((5,6,7-trimethoxy-1H-indol-2-yl )carbonyl)-, methyl ester
| 134106-75-5 |
|
Benzo(1,2-b4,3-b')dipyrrole-1-carboxylic acid,3,6,7,8-tetrahydro-8-(bromomethyl)-4-(((1,1-dimethylethyl)dimethylsilyl)oxy)-2-methyl-6-((5,6,7-trimethoxy-1H-indol-2- yl)carbonyl)-, methyl ester
| 134127-18-7 |
|
Benzo(1,2-b4,3-b')dipyrrole-1-carboxylic acid,3,6,7,8-tetrahydro-8-(bromomethyl)-2-methyl-4-(((4-methyl-1-piperazinyl)carbonyl)oxy)-6-((5,6,7-trimethoxy-1H-indol-2-yl)carbonyl)-, methyl ester
| 134106-78-8 |
|
5H-Benzocyclohepten-5-ol, 6,7,8,9-tetrahydro-
| 35550-94-8 |
|
Benzo(1,2-b4,3-b')dipyrrole-1-carboxylic acid,3,6,7,8-tetrahydro-8-(bromomethyl)-2-methyl-4-(((4-methyl-1-piperazinyl)carbonyl)oxy)-6-((5,6,7-trimethoxy-1H-indol-2-yl)carbonyl)-, methyl ester, monohydrochloride
| 134106-80-2 |
|
Benzo(1,2-b4,3-b')dipyrrole-1-carboxylic acid,3,6,7,8-tetrahydro-8-(bromomethyl)-2-methyl-4-((1-piperidinylcarbonyl)oxy)-6-((5,6,7-trimethoxy-1H-indol-2-yl)carbonyl)-,methyl ester
| 134106-76-6 |
|
Benzo(1,2-b4,3-b')dipyrrole-1-carboxylic acid,3,6,7,8-tetrahydro-8-(bromomethyl)-2-methyl-4-((1-pyrrolidinylcarbonyl)oxy)-6-((5,6,7-trimethoxy-1H-indol-2-yl)carbonyl)-,methyl ester
| 134106-77-7 |
|
Benzo(1,2-b4,3-b')dipyrrole-1-carboxylic acid,3,6,7,8-tetrahydro-8-(chloromethyl)-4-hydroxy-2-methyl-6-((5,6,7-trimethox y-1H-indol-2-yl)carbonyl)-,methyl ester
| 134106-66-4 |
|
Benzo(1,2-b3,4-b')dipyrrole-3,8-dimethanaminium,1,6-dihydro-2,7-bis(ethoxycarbonyl)-N,N,N,N',N',N'-hexamethyl-, bis(methylsulfate)
| 72990-72-8 |
|
Benzo(1,2-b5,4-b')dipyrrole-3,5-dimethanaminium,1,7-dihydro-2,6-bis(ethoxycarbonyl)-N,N,N,N',N',N'-hexamethyl-, bis(methyl sulfate)
| 90094-65-8 |
|
1,4,2-Benzodithiazine-7-carboxylic acid,2,3-dihydro-6-chloro-3-thioxo-, 1,1-dioxide
| 94640-53-6 |
|
2H-1,3,4-Benzodithiazin-3-ium, 7-ethoxy-, chloride
| 94640-53-6 |
|
Benzo(ghi)fluoranthene
| 203-12-3 |
|
Benzo(j)fluoranthene
| 205-82-3 |
|
5H-Benzocyclohepten-5-ol,6,7,8,9-tetrahydro-6-amino-, cis-
| 23445-16-1 |
|
Benzo(k)fluoranthene
| 207-08-9 |
|
Benzo(k)fluoranthene, 7,12-dimethyl-
| 95741-56-3 |
|
Benzo(j)fluoranthene-4,5-diol, 4,5-dihydro-
| 151258-40-1 |
|
Benzo(j)fluoranthene-9,10-diol, 9,10-dihydro-
| 100333-37-7 |
|
Benzo(k)fluoranthene-2,3-diol, 2,3-dihydro-
| 100333-37-7 |
|
Benzo(k)fluoranthene-8,9-diol, 8,9-dihydro-
| 100310-95-0 |
|
Benzo(k)fluoranthene-2,3-dione
| 112575-91-4 |
|
Benzo(j)fluoranthene, 4-fluoro-
| 129286-36-8 |
|
Benzo(j)fluoranthene, 10-fluoro-
| 129286-37-9 |
|
Benzo(k)fluoranthene, 3-fluoro-
| 116208-67-4 |
|
5H-Benzocyclohepten-1-ol,6,7,8,9-tetrahydro-8-amino-2,3-dimethoxy-
| 49562-05-2 |
|
Benzo(k)fluoranthene, 8-fluoro-
| 113600-17-2 |
|
Benzo(k)fluoranthene, 9-fluoro-
| 113600-15-0 |
|
Benzo(k)fluoranthene, 2-methyl-
| 95741-57-4 |
|
Benzo(k)fluoranthene, 3-nitro-
| 81316-80-5 |
|
11H-Benzo(7,8)fluorantheno(1,10b-b)oxirene-11,12-diol, 12,12a-dihydro-,(11S-(1aR*,11-alpha,12-beta,12a-alpha))-
| 151378-31-3 |
|
|